<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Emory_Human_Practices skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Emory/Human Practices</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="igem_2018_team_menu displaying_menu"><A href="https://2018.igem.org/Team:Emory"><DIV class="menu_item direct_link">
				HOME
			</DIV></A><DIV class="menu_item">
			TEAM
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:Emory/Team"><DIV class="submenu_item">
					Team Members
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Attributions"><DIV class="submenu_item">
					Attributions 
				</DIV></A></DIV><DIV class="menu_item">
			PROJECT
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:Emory/Description"><DIV class="submenu_item">
					Description
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Design"><DIV class="submenu_item">
					Design
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Experiments"><DIV class="submenu_item">
					Experiments
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Notebook"><DIV class="submenu_item">
					Notebook
				</DIV></A><A href="https://2018.igem.org/Team:Emory/InterLab"><DIV class="submenu_item">
					InterLab
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Results"><DIV class="submenu_item">
					Results
				</DIV></A></DIV><DIV class="menu_item">
			PARTS
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:Emory/Parts"><DIV class="submenu_item">
					Parts Overview
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Basic_Part"><DIV class="submenu_item">
					Basic Parts
				</DIV></A></DIV><A href="https://2018.igem.org/Team:Emory/Safety"><DIV class="menu_item direct_link">
				SAFETY
			</DIV></A><DIV class="menu_item"> 
			HUMAN PRACTICES 
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:Emory/Human_Practices"><DIV class="submenu_item">
					Human Practices
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Public_Engagement"><DIV class="submenu_item">
					Education &amp; Engagement
				</DIV></A><A href="https://2018.igem.org/Team:Emory/Collaborations"><DIV class="submenu_item">
					Collaborations
				</DIV></A></DIV><A href="https://igem.org/2018_Judging_Form?team=Emory"><DIV class="menu_item direct_link">
				JUDGING FORM â‡— 
			</DIV></A></DIV><DIV class="igem_2018_team_content"><DIV class="igem_2018_team_column_wrapper"><DIV class="column full_size"><H1>Human Practices</H1><P>
Our experimental results suggest that recombinant bacteria, as opposed to protein purified from such a bacterium, could be applied to inactivate environmental toxins such as the organophosphate insecticide malathion. We suspected, however, that many people in our locale (Atlanta, Georgia, U.S.A.) and elsewhere fear genetically modified (GM) bacteria more than of proven toxins. 

</P><P>
We sought to test public opinion, but supposed that our project would confuse people. We approached passers-bye in their homes, at grocery stores or at a meeting of home poultry farmers and asked them how they would feel about a GM probiotic for chickens that would make meat and eggs more nutritious. Only three of the 28 consumers we interviewed would buy such a product.

</P><P>
The results of our unscientific survey were consistent with those of more systematic studies of consumer attitudes [ S. Wunderlich, K. A. Gatto, Adv Nutr 6, 842-851 (2015) ]. Scientific education is correlated with acceptance of GM foods, and more Americans are going to college. Other GM foods, materials and medical treatments will be reaching the market in the near future, and the proliferation of such products could cause some consumers to reconsider their stance. 

</P><P>
We intend to continue listening to members of the lay public, and develop GM products that solve generally recognized problems.


</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>